tirzepatide latest news FDA Grants a New Indication for Obesity Management Peptide of the Week: Tirzepatide,

Primarily, Ozempic is clinically engineered and approved to improve blood sugar control in adults with Type 2 Diabetes

Whats happening The filings target generic versions of the tirzepatide autoinjector, designed to compete directly with: - Mounjaro for type 2 diabetes management - Zepbound for chronic weight management and related conditions Together, these cover the full range of currently approved indications in the U.S

doi:10.2337/dc15-0109

Medical assessment remains important before starting treatment

Paradoxically, obese individuals exhibit leptin resistance, possibly due to blood-brain barrier (BBB) saturation, rendering exogenous leptin administration ineffective in treating obesity

Adjust based on symptoms, activity, and climate